339 25 Pill: yellow, round, 9mm
The pill with imprint 339 25 (Yellow, Round, 9mm) has been identified as Lamotrigine Extended-Release 25 mg and is used for Bipolar Disorder, Lennox-Gastaut Syndrome, Seizure Prevention, Epilepsy, and Seizures. It belongs to the drug class triazine anticonvulsants and is not a controlled substance.
Images for 339 25
Lamotrigine Extended-Release
- Imprint
- 339 25
- Strength
- 25 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Torrent Pharmaceuticals Limited
- National Drug Code (NDC)
- 13668-0339
- Inactive Ingredients
-
diethyl phthalate,
ferric oxide yellow,
hypromellose 2910 (6 mPa.s),
hypromellose phthalate (31% phthalate, 40 cst),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,849)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
- Lamotrigine Tablets (FDA)
- Lamotrigine, tablets for suspension (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.